These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 17610286)
21. MR imaging of the pancreas. Pamuklar E; Semelka RC Magn Reson Imaging Clin N Am; 2005 May; 13(2):313-30. PubMed ID: 15935314 [TBL] [Abstract][Full Text] [Related]
22. MR dynamic Gadolinium-enhanced fast multiplanar spoiled gradient-echo and spin-echo T1-weighted fat-suppressed techniques in diagnosis of pancreatic carcinoma. Zeng MS; Yan FH; Zhou KR; Chen ZW; Sun JZ; Chen CZ; Shi WB Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):294-8. PubMed ID: 14612288 [TBL] [Abstract][Full Text] [Related]
23. Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. Ramalho M; Herédia V; Tsurusaki M; Altun E; Semelka RC J Magn Reson Imaging; 2009 Apr; 29(4):869-79. PubMed ID: 19306415 [TBL] [Abstract][Full Text] [Related]
24. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation]. Dobritz M; Fellner FA; Baum U; Nömayr A; Lell M; Klein P; Papadopoulos T; Bautz W Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481 [TBL] [Abstract][Full Text] [Related]
25. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Klauss M; Lemke A; Grünberg K; Simon D; Re TJ; Wente MN; Laun FB; Kauczor HU; Delorme S; Grenacher L; Stieltjes B Invest Radiol; 2011 Jan; 46(1):57-63. PubMed ID: 21139505 [TBL] [Abstract][Full Text] [Related]
26. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease. Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354 [TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. Hur BY; Lee JM; Lee JE; Park JY; Kim SJ; Joo I; Shin CI; Baek JH; Kim JH; Han JK; Choi BI J Magn Reson Imaging; 2012 Jul; 36(1):188-97. PubMed ID: 22371378 [TBL] [Abstract][Full Text] [Related]
29. Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI. Birchard KR; Semelka RC; Hyslop WB; Brown A; Armao D; Firat Z; Vaidean G AJR Am J Roentgenol; 2005 Sep; 185(3):700-3. PubMed ID: 16120921 [TBL] [Abstract][Full Text] [Related]
30. [Studies on magnetic resonance imaging of pancreatic cancer]. Hirose Y Nihon Geka Hokan; 1991 Sep; 60(5):316-26. PubMed ID: 1820003 [TBL] [Abstract][Full Text] [Related]
31. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings. Alkaade S; Cem Balci N; Momtahen AJ; Burton F J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530 [TBL] [Abstract][Full Text] [Related]
32. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628 [TBL] [Abstract][Full Text] [Related]
33. MR imaging of pancreatic disorders. Outwater EK; Siegelman ES Top Magn Reson Imaging; 1996 Oct; 8(5):265-89. PubMed ID: 8914226 [TBL] [Abstract][Full Text] [Related]
34. State-of-the-art magnetic resonance imaging of pancreatic cancer. Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400 [TBL] [Abstract][Full Text] [Related]